tiprankstipranks
Trending News
More News >
QT Imaging Holdings (QTIH)
OTHER OTC:QTIH
US Market

QT Imaging Holdings (QTIH) AI Stock Analysis

Compare
58 Followers

Top Page

QTIH

QT Imaging Holdings

(OTC:QTIH)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
$5.50
▼(-7.56% Downside)
The score is held down primarily by very weak financial performance (deep losses, negative equity, and sustained cash burn). Technicals are also soft with price below key short/intermediate moving averages and negative MACD. Corporate actions (PIPE financing and debt repayment, Nasdaq relisting steps) provide some offset by improving liquidity and potential market access, but valuation remains difficult to justify while the company is unprofitable.
Positive Factors
Revenue Growth
The significant revenue growth indicates strong market demand and successful product adoption, enhancing the company's competitive position in the medical imaging industry.
Strategic Partnerships
The new distribution partnership in Saudi Arabia expands QT Imaging's market reach, potentially increasing sales and strengthening its international presence.
Financial Restructuring
The financial restructuring enhances QT Imaging's balance sheet, providing greater financial stability and flexibility to support ongoing operations and growth initiatives.
Negative Factors
Negative Profitability
Deep negative profitability indicates ongoing financial challenges, potentially limiting the company's ability to invest in growth and innovation without external funding.
Cash Burn
Sustained cash burn pressures QT Imaging's financial resources, necessitating continuous external financing to maintain operations, which could dilute shareholder value.
Negative Equity
Negative equity reflects a vulnerable financial position, limiting QT Imaging's ability to absorb losses and potentially impacting its long-term viability if not addressed.

QT Imaging Holdings (QTIH) vs. SPDR S&P 500 ETF (SPY)

QT Imaging Holdings Business Overview & Revenue Model

Company DescriptionGigCapital5 Inc is a blank check company.
How the Company Makes MoneyQT Imaging Holdings makes money through the sale and leasing of its imaging equipment to healthcare providers, including hospitals, clinics, and diagnostic centers. Additionally, the company may generate revenue from service agreements for maintenance and support of their imaging systems. QTI could also engage in strategic partnerships or collaborations with other medical technology companies to expand their market reach and drive sales. Revenue may also be supplemented by research and development grants, as well as potential licensing of their proprietary imaging technologies to third parties.

QT Imaging Holdings Financial Statement Overview

Summary
QT Imaging Holdings is currently facing a challenging financial situation. Despite a positive revenue growth trajectory, the company struggles with profitability and sustainability, as highlighted by negative profit margins and high leverage. The reliance on external financing to maintain operations and a negative stockholders' equity position emphasize the potential risks and need for strategic improvements.
Income Statement
18
Very Negative
QT Imaging Holdings has shown a significant increase in revenue over the TTM period, moving from zero to $4,032,168, indicating a positive growth trajectory. However, the company is struggling with profitability, as evidenced by negative profit margins: Gross Profit Margin at 53.4%, Net Profit Margin at -375.3%, and negative EBIT and EBITDA margins, indicating substantial operational losses.
Balance Sheet
9
Very Negative
The balance sheet reveals a highly leveraged position with a negative stockholders' equity of -$9,651,660, resulting in an undefined Debt-to-Equity Ratio. The negative equity ratio highlights potential solvency issues, while assets have decreased significantly. The company's high debt level poses a significant risk.
Cash Flow
12
Very Negative
Cash flow analysis indicates negative free cash flow growth, with TTM free cash flow deteriorating further to -$9,461,768. The operating cash flow to net income ratio is 0.62, reflecting operational cash constraints. The company is heavily reliant on financing activities to support cash requirements, as seen from significant financing cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue10.65M4.88B0.00708.24K365.15K
Gross Profit5.44M2.64B0.00151.32K104.58K
EBITDA-6.04M-12.18B-3.39M-2.26M-4.27M
Net Income-8.56M-14.17B-5.13M-6.26M-5.42M
Balance Sheet
Total Assets12.12M6.09B23.40M7.75M8.46M
Cash, Cash Equivalents and Short-Term Investments1.74M1.19B2.44K455.08K1.53M
Total Debt9.95M9.91B3.07M7.86M4.23M
Total Liabilities21.20M15.62B12.69M9.26M5.52M
Stockholders Equity-9.08M-9.54B10.71M-1.51M2.94M
Cash Flow
Free Cash Flow-5.91M-10.12B-1.94M-3.88M-2.72M
Operating Cash Flow-5.86M-10.03B-1.94M-3.86M-2.70M
Investing Cash Flow-47.00K-87.79M19.92M-22.60K-18.37K
Financing Cash Flow6.45M11.13B-18.05M2.78M3.67M

QT Imaging Holdings Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5.95
Price Trends
50DMA
6.06
Negative
100DMA
6.59
Negative
200DMA
5.10
Positive
Market Momentum
MACD
-0.12
Negative
RSI
51.10
Neutral
STOCH
73.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For QTIH, the sentiment is Positive. The current price of 5.95 is above the 20-day moving average (MA) of 5.77, below the 50-day MA of 6.06, and above the 200-day MA of 5.10, indicating a neutral trend. The MACD of -0.12 indicates Negative momentum. The RSI at 51.10 is Neutral, neither overbought nor oversold. The STOCH value of 73.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QTIH.

QT Imaging Holdings Risk Analysis

QT Imaging Holdings disclosed 83 risk factors in its most recent earnings report. QT Imaging Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

QT Imaging Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
52
Neutral
$42.54M-0.26-191.12%-24.38%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
$75.48M-1.25-73.73%15.59%4.13%
45
Neutral
$46.97M-2.66-157.91%-18.96%8.98%
44
Neutral
$70.22M-2.75-1536.16%185.12%21.22%
42
Neutral
$50.83M-0.40-141.82%-55.88%6.14%
41
Neutral
$49.41M-2.08-15.02%-11.06%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
QTIH
QT Imaging Holdings
5.75
4.35
310.71%
JSPR
Jasper Therapeutics
1.53
-3.98
-72.23%
LUNG
Pulmonx
1.77
-4.49
-71.73%
ALGS
Aligos Therapeutics
7.94
-26.30
-76.81%
MDAI
Spectral AI
1.56
-0.40
-20.41%
ICCM
Icecure Medical
0.68
-0.52
-43.33%

QT Imaging Holdings Corporate Events

Financial DisclosuresPrivate Placements and FinancingRegulatory Filings and Compliance
QT Imaging releases pro forma results after October financing
Neutral
Dec 23, 2025

On December 23, 2025, QT Imaging Holdings furnished unaudited pro forma condensed consolidated statements of operations and comprehensive loss for the quarters ended December 31, 2024 and March 31, June 30, and September 30, 2025, reflecting the impact of a private placement completed in October 2025 and related debt transactions as if they had occurred on January 1, 2024. The pro forma information gives effect to the $18.2 million private placement that closed on October 3, 2025, the October 6, 2025 repayment of $5 million in long-term debt plus accrued interest and a premium to Lynrock Lake, the elimination of expenses tied to extinguished or modified debt and the February 2025 Lynrock Lake term loan, and the exclusion of certain non-cash items such as interest, warrant, derivative and earnout fair-value adjustments, in order to present a non-GAAP view that management says better illustrates the company’s cash burn rate and underlying operating performance for stakeholders.

The most recent analyst rating on (QTIH) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on QT Imaging Holdings stock, see the QTIH Stock Forecast page.

Financial DisclosuresPrivate Placements and Financing
QT Imaging Holdings Releases Financial Impact of Private Placement
Positive
Dec 11, 2025

On December 11, 2025, QT Imaging Holdings, Inc. released unaudited pro forma financial information reflecting the impact of a private placement of securities that occurred on September 30, 2025, and closed on October 3, 2025, raising approximately $18.18 million. The financial data also accounts for the repayment of $5 million in long-term debt and associated interest to Lynrock Lake Master Fund LP, as if these transactions had occurred on January 1, 2025, indicating a strategic financial restructuring aimed at enhancing the company’s balance sheet.

The most recent analyst rating on (QTIH) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on QT Imaging Holdings stock, see the QTIH Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
QT Imaging Releases Investor Presentation on Website
Neutral
Nov 10, 2025

On November 10, 2025, QT Imaging Holdings, Inc. released an investor presentation on its website, providing supplemental product and operational information. This release, which is part of a Current Report on Form 8-K, is intended to inform stakeholders but is not considered filed under the Exchange Act, thus not subject to certain liabilities.

The most recent analyst rating on (QTIH) stock is a Buy with a $3.40 price target. To see the full list of analyst forecasts on QT Imaging Holdings stock, see the QTIH Stock Forecast page.

Business Operations and StrategyExecutive/Board ChangesDelistings and Listing ChangesFinancial DisclosuresPrivate Placements and Financing
QT Imaging Reports Strong Q3 2025 Financial Results
Positive
Nov 10, 2025

QT Imaging Holdings reported strong financial results for the third quarter of 2025, with a revenue of $4.2 million, marking a 339% year-over-year growth. The company has strengthened its financial position through an $18.2 million PIPE transaction and is advancing its global expansion with a new distribution partner in Saudi Arabia. QT Imaging has also applied to relist on Nasdaq and appointed new executives to bolster its leadership team. The company is focusing on transforming its business model towards a scalable imaging platform, integrating AI/ML and biomarker science to enhance breast imaging. Additionally, QT Imaging has increased its revenue outlook for 2026, following a new distribution agreement in Saudi Arabia.

The most recent analyst rating on (QTIH) stock is a Buy with a $3.40 price target. To see the full list of analyst forecasts on QT Imaging Holdings stock, see the QTIH Stock Forecast page.

Business Operations and StrategyStock Split
QT Imaging Implements 3:1 Reverse Stock Split
Neutral
Oct 24, 2025

On October 24, 2025, QT Imaging Holdings, Inc. implemented a 3:1 reverse stock split of its common stock, which became effective on the market on the same day. This adjustment also affected the company’s public warrants, altering their exercise price and share conversion rate. The reverse stock split is managed by Continental Stock Transfer and Trust Company, with stockholders receiving instructions on how to handle their shares. This move is part of QT Imaging’s strategic efforts to optimize its stock structure and potentially improve its market position.

The most recent analyst rating on (QTIH) stock is a Buy with a $3.40 price target. To see the full list of analyst forecasts on QT Imaging Holdings stock, see the QTIH Stock Forecast page.

Stock Split
QT Imaging Holdings Announces Reverse Stock Split
Neutral
Oct 23, 2025

QT Imaging Holdings, Inc. announced that its board of directors has approved a reverse stock split at a ratio of 3:1, meaning every three shares of common stock will be consolidated into one. This decision, effective from October 23, 2025, aims to adjust the trading price of the company’s stock, which will begin trading on a reverse split-adjusted basis on the OTCQB Venture Market starting October 24, 2025.

The most recent analyst rating on (QTIH) stock is a Buy with a $3.40 price target. To see the full list of analyst forecasts on QT Imaging Holdings stock, see the QTIH Stock Forecast page.

Delistings and Listing ChangesStock Split
QT Imaging Holdings Plans Nasdaq Relisting and Stock Split
Positive
Oct 20, 2025

On October 20, 2025, QT Imaging Holdings announced its application to relist on the Nasdaq Capital Market and a 3:1 reverse stock split approved by its Board of Directors. This strategic move, less than a year after leaving the exchange, is intended to meet Nasdaq’s listing requirements and reflects the company’s growth momentum, aiming to enhance long-term shareholder value and attract a broader investor base. The reverse stock split will take effect on October 23, 2025, reducing the company’s outstanding shares significantly and adjusting stockholder records accordingly.

The most recent analyst rating on (QTIH) stock is a Buy with a $3.40 price target. To see the full list of analyst forecasts on QT Imaging Holdings stock, see the QTIH Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025